Developed by scientists at New York University’s Tandon School of Engineering, the system instructs manufacturers’ 3D printers to include hundreds of tiny elements within objects, as they’re being printed. These elements are made up of inert materials, they’re located in various layers within the object, and they reportedly don’t compromise its structural integrity.
Susquehanna Bancshares set a $16.00 price objective on 3D Systems (NYSE:DDD) in a research note issued to investors on Friday, August 10th. The brokerage currently has a hold rating on the 3D printing companyâ€™s stock.
DDD has been the topic of a number of other research reports. Zacks Investment Research raised 3D Systems from a sell rating to a hold rating in a research report on Tuesday, July 3rd. ValuEngine raised 3D Systems from a sell rating to a hold rating in a research report on Wednesday, May 2nd. JPMorgan Chase & Co. set a $9.00 price target on 3D Systems and gave the stock a sell rating in a research report on Thursday, May 3rd. Loop Capital boosted their price target on 3D Systems to $17.00 and gave the stock a hold rating in a research report on Wednesday, August 8th. They noted that the move was a valuation call. Finally, B. Riley boosted their price target on 3D Systems from $7.00 to $9.00 and gave the stock a sell rating in a research report on Wednesday, August 8th. Six research analysts have rated the stock with a sell rating, seven have assigned a hold rating, two have given a buy rating and two have issued a strong buy rating to the companyâ€™s stock. The stock has a consensus rating of Hold and a consensus price target of $13.49.
NYSE DDD traded down $0.18 during trading on Friday, reaching $19.04. 2,302,513 shares of the companyâ€™s stock were exchanged, compared to its average volume of 2,813,860. The company has a market cap of $2.27 billion, a PE ratio of -33.40 and a beta of 1.26. The company has a quick ratio of 1.44, a current ratio of 1.95 and a debt-to-equity ratio of 0.01. 3D Systems has a fifty-two week low of $7.92 and a fifty-two week high of $20.00.
3D Systems (NYSE:DDD) last announced its quarterly earnings results on Tuesday, August 7th. The 3D printing company reported $0.06 earnings per share for the quarter, topping analystsâ€™ consensus estimates of ($0.06) by $0.12. The firm had revenue of $176.57 million for the quarter, compared to the consensus estimate of $165.83 million. 3D Systems had a negative return on equity of 9.22% and a negative net margin of 11.54%. research analysts anticipate that 3D Systems will post -0.15 EPS for the current fiscal year.
In related news, Director G Walter Loewenbaum II purchased 4,500 shares of the businessâ€™s stock in a transaction that occurred on Tuesday, May 29th. The stock was acquired at an average cost of $12.06 per share, for a total transaction of $54,270.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Andrew Martin Johnson sold 5,000 shares of the businessâ€™s stock in a transaction that occurred on Friday, August 17th. The shares were sold at an average price of $19.01, for a total value of $95,050.00. The disclosure for this sale can be found here. 5.00% of the stock is currently owned by corporate insiders.
Hedge funds have recently modified their holdings of the stock. Alps Advisors Inc. bought a new stake in shares of 3D Systems in the first quarter valued at approximately $117,000. Oppenheimer & Co. Inc. bought a new stake in shares of 3D Systems in the first quarter valued at approximately $120,000. Private Advisor Group LLC bought a new stake in shares of 3D Systems in the first quarter valued at approximately $147,000. Xact Kapitalforvaltning AB bought a new stake in shares of 3D Systems in the fourth quarter valued at approximately $116,000. Finally, CIBC Asset Management Inc bought a new stake in shares of 3D Systems in the second quarter valued at approximately $205,000. Institutional investors and hedge funds own 66.07% of the companyâ€™s stock.
3D Systems Company Profile
3D Systems Corporation, through its subsidiaries, provides three-dimensional (3D) printing products and services worldwide. The company offers 3D printers, such as stereolithography, selective laser sintering, direct metal printing, multi jet printing, and color jet printers that transform data input generated by 3D design software, CAD software, or other 3D design tools into printed parts under the Accura, DuraForm, LaserForm, CastForm, and VisiJet brand names.
Further Reading: Closed-End Mutual Funds (CEFs)
Receive News & Ratings for 3D Systems Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for 3D Systems and related companies with MarketBeat.com’s FREE daily email newsletter.
A new biomaterial company, Â FibreTuff,Â has announced plans to begin manufacturing cellulose-based biomaterials that are biocompatible, absorbable, and nondegradable for Class I and II medical devices. The companyâ€™s PAPC ingredients can be compounded into pellets to make 3D printing filament that can be used to print a variety of medical devices and implants.
â€œFibreTuff compounds biomaterials that contain celluloseÂ and blends them with thermoplastics branded as PAPC (polyamide, polyolefin, and cellulose) compositions for use in Class I [and]Â IIÂ and eventually Class III permanent implants for the medical industry,â€� explainedÂ FibreTuff founder and president Robert Joyce. â€œWeâ€™ve now brought on partners, purchased manufacturing equipment, and now leased space in a facility located in West Unity, Ohio.â€�
FibreTuffâ€™s PAPC filament can be used in 3D printers without the odors traditionally associated with the printing process. The biomaterial will also cost about 30% less for device makers in need of things like cervical spacers and other implantable devices. The material also has the huge advantage of being â€œradiopaque,â€� meaning it can be seen onÂ an x-ray without requiring additives like other products on the market.
â€œYou can see in an x-ray where the tissues and bone grow into the implant made with PAPC,â€� Joyce said. â€œOur FibreTuff PAPC is a hydrophilic compound that is coating friendly to support a printed circuits design and construction through an ink process by nScrypt located in Orlando, Florida. Even the specific gravity of the compound is 20% lighter than [that of] other materials currently on the market, which can translate into lower material costs to produce 3D printed parts.â€�
Among the other characteristics of the FibreTuff filament are that it will not dissolve inside the bodyÂ and has already passed USP Class VI testing performed by NAMSA for implantation, the company reported in a news release. The filament also has a weight and composition very similar to actual human bone, which could suit it for 3D printing bones for academic use in medical school.
â€œThe human bones that are 3D printed with FibreTuff PAPC offer similar features to an actual human experience, having good screw retentionÂ and sawing and cutting ability,â€� Joyce said. â€œOther 3D printed resins have challenges with these types of features, but we have the flexibility to print different sizes of human bone that actually resemble real human bones. A local university has been using pig and cow bones for their medical students to practice on, but we are aiming to have the students 3D print bones with FibreTuff PAPC that they can actually practice on.â€�
While the company officially launched operations within the last week, the company has spent the last four years not only developing the technology, but also recruiting partners and taking orders. Now that it is moving toward a new phase in sales and marketing, Joyce saidÂ that the company hopes to begin producing PAPC implants within the next 16 months.
â€œApproximately 16 months from now we hope to have PAPC in permanent implants for spine, trauma, and sports medicine that can show much improved osseointegration versus PEEK and metal implants,â€� he said. â€œWe also hope to begin reducing the cost to produce these types of implants by 30%. We want to work with hospitals, colleges and universities, and medical device manufacturers to develop a new way to deliver education and functional tools and models to the medical market.â€�